Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases

Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases

Transarterial chemoembolisation with irinotecan-loaded drug-eluting beads (DEBIRI TACE) can be considered in patients with unresectable colorectal cancer liver metastases (CRLM) who progress after all approved standard therapies or in patients unsuitable for systemic therapy.

Bibliographic Details
Main Authors: Sljivic Maja, Sever Masa, Ocvirk Janja, Mesti Tanja, Brecelj Erik, Popovic Peter
Format: Article
Language:English
Published: Sciendo 2024-03-01
Series:Radiology and Oncology
Subjects:
colorectal cancer
liver metastases
irinotecan
drug-eluting beads
transarterial chemoembolization
survival
Online Access:https://doi.org/10.2478/raon-2024-0023

Internet

https://doi.org/10.2478/raon-2024-0023

Similar Items